UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054801
Receipt number R000062623
Scientific Title A study to investigate the effects of resistance training combined with supplementation of functional food ingredient on skeletal muscle mass and physical function in the elderly.
Date of disclosure of the study information 2025/05/30
Last modified on 2025/06/27 13:27:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to investigate the effects of resistance training combined with supplementation of functional food ingredient on skeletal muscle mass and physical function in the elderly.

Acronym

A study to investigate the effects of resistance training combined with supplementation of functional food ingredient on skeletal muscle mass and physical function in the elderly.

Scientific Title

A study to investigate the effects of resistance training combined with supplementation of functional food ingredient on skeletal muscle mass and physical function in the elderly.

Scientific Title:Acronym

A study to investigate the effects of resistance training combined with supplementation of functional food ingredient on skeletal muscle mass and physical function in the elderly.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the effects of resistance training combined with orally administrated functional food ingredient on skeletal muscle mass and physical function in the elderly and the efficacy to prevent sarcopenia.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Muscle thickness of anterior thigh at 12 weeks

Key secondary outcomes

Muscle thickness of anterior thigh at 6 and 18 weeks
The 30-s chair stand test (CS-30), walking speed, and body composition at 6, 12 and 18 weeks.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of test food containing lemon myrtle extract for 18 weeks combined with resistance training for 12 weeks and follow-up for 6 weeks

Interventions/Control_2

Intake of test food not containing lemon myrtle extract for 18 weeks combined with resistance training for 12 weeks and follow-up for 6 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1. Subjects who are over 65 years old and healthy males and females.
2. Subjects who are aware of getting worse of muscle mass or muscle strength.
3. Subjects who have the trend of decrease in muscle mass.

Key exclusion criteria

1. Subjects who take antidiabetic medicines.
2. Subjects who are prohibited from exercising by a doctor.
3. Subjects with symptoms that interfere with training, such as lower back pain or arthralgia.
4. Subjects who take supplements, functional foods or medicines in order to improve of symptoms related to muscle or arthrosis on
a daily basis.
5. Subjects who go to health club on a daily basis.
6. Subjects who participating in other clinical trials, have plans to participate in other clinical trials during the period of this study or finished to participate in other clinical trials in 3 months.
7. Subjects who are considerably undernutrition.
8. Subjects who are judged to be ineligible by a doctor.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Shuichi
Middle name
Last name Machida

Organization

Juntendo University

Division name

Graduate School of Health and Sports Science

Zip code

270-1695

Address

1-1 Hirakagakuendai, Inzai, Chiba 270-1695, Japan

TEL

0476-98-1001

Email

machidas@juntendo.ac.jp


Public contact

Name of contact person

1st name Azusa
Middle name
Last name Nishino

Organization

KANEKA CORPORATION

Division name

Healthy Foods Strategic Unit

Zip code

530-8288

Address

2-3-18, Nakanoshima, Kita-ku Osaka 530-8288, Japan

TEL

050-3133-8731

Homepage URL


Email

Azusa.Nishino@kaneka.co.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

KANEKA CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee in Juntendo University Graduate School of Health and Sports Science

Address

1-1 Hirakagakuendai, Inzai, Chiba

Tel

0476-98-1001

Email

sc-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 06 Month 26 Day

Date of IRB

2024 Year 06 Month 26 Day

Anticipated trial start date

2024 Year 08 Month 15 Day

Last follow-up date

2025 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 06 Month 27 Day

Last modified on

2025 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062623